Earnings Ahead

ILMN - Illumina

183.43 -8.45 -4.4

  1. Home
  2. Healthcare
  3. ILMN
Illumina

Illumina

About

Profile

A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human

Headquarters

San Diego, California, United States

Intraday

High
-
Low
-

52-week

High
-
Low
-

ILMN



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Illumina rises as Carl Icahn sees positives in CEO transition (update)
  • Illumina CEO Francis deSouza resigns
  • House Republicans seek information from FTC over Illumina's Grail deal
  • Illumina unit Grail in hot water over erroneous cancer results – FT
  • Illumina names Hologic CEO as chair, elects Edwards CFO to board
  • Illumina launches AI software to predict disease-causing genetic mutations
  • Illumina stock declines as shareholder voting results overdone - Evercore
  • Icahn holdings Illumina, CVR Energy drop amid Icahn Enterprises' weakness
  • Illumina chairman out, CEO survives, one Icahn nominee elected
  • Illumina director says company prepared if CEO, chairman tossed out - FT
  • Carl Icahn adds Illumina in Q1, cuts stakes in Herc, Newell Brands
  • Illumina board tells shareholders to ignore Carl Icahn's 'unfit associates'
  • Illumina wins partial victory in Icahn battle as proxy firm ISS backs CEO DeSouza
  • Glass Lewis backs Carl Icahn attempt to replace Illumina CEO and chair
  • Carl Icahn urges Illumina to divest GRAIL as soon as possible
  • Illumina DNA sequencing devices could be vulnerable to hackers - FDA
  • Illumina unveils $100M annual cost cutting plan
  • Illumina Non-GAAP EPS of $0.08 beats by $0.05, revenue of $1.09B beats by $20M
  • Illumina under the spotlight as Q1 earnings approach
  • Carl Icahn further accuses Illumina board of 'obfuscation'

Earnings History

Date EPS / Forecast Revenue / Forecast
February 10, 2022 0.75 / 0.4562 1.2B / 1.13B Beat!
November 4, 2021 1.45 / 1.31 1.11B / 1.05B Beat!
August 5, 2021 1.87 / 1.36 1.13B / 1.02B Beat!
April 27, 2021 1.89 / 1.39 1.09B / 996.34M
February 11, 2021 1.22 / 1.11 953M / 903.91M Beat!
January 27, 2021 - / 1.42 - / 870.51M
October 29, 2020 1.02 / 0.813 794M / 715.83M Beat!
August 6, 2020 0.62 / 0.67 633M / 679.55M
April 30, 2020 1.64 / 1.26 859M / 853.91M Beat!
January 29, 2020 1.7 / 1.58 953M / 942.43M Beat!
October 24, 2019 1.93 / 1.4 907M / 870.9M Beat!
July 29, 2019 1.35 / 1.34 838M / 855.87M
April 25, 2019 1.6 / 1.34 846M / 834.28M Beat!
January 29, 2019 1.32 / 1.36 867M / 862.81M Beat!
October 23, 2018 1.52 / 1.26 853M / 828.24M Beat!
July 30, 2018 1.43 / 1.11 830M / 787.43M Beat!
April 24, 2018 1.45 / 1.02 782M / 744.3M Beat!
January 30, 2018 1.44 / 1.22 714.0M / 750.24M
October 24, 2017 1.11 / 0.99 662.0M / 692.84M
August 1, 2017 0.82 / 0.69 598.0M / 642.36M
April 25, 2017 0.64 / 0.64 598M / 590.75M Beat!